01—Abstract
Summary
Summary of the 8-K filed March 20, 2025. Cited figures are marked; the original filing is the authoritative source.
Roivant Sciences Ltd. (ROIV) filed this Current Report on Form 8-K on March 20, 2025 to disclose a change in its accounting leadership.
Under Item 5.02, on March 16, 2025, its wholly-owned subsidiary Roivant Sciences, Inc. ("RSI") entered into a consulting agreement with Rakhi Kumar, its former Chief Accounting Officer. The filing notes that Ms. Kumar had stepped down from that role effective February 20, 2025, as previously disclosed in a Form 8-K filed on February 21, 2025. The consulting agreement has an 18-month term during which Ms. Kumar will provide advisory and transition services as reasonably requested by RSI.
In consideration, she will remain eligible to continue vesting in her outstanding Company equity incentive awards during that term. At the end of the term, provided she has complied with her obligations and the agreement has not been earlier terminated, any outstanding and unvested equity awards will fully vest. The filing contains no financial statements and no financial figures.
Its only exhibit is the cover page Interactive Data File embedded in the Inline XBRL document. For investors, the filing is a routine executive transition disclosure that documents continuity of transition support and a retention-style equity arrangement for a departing officer.
02—Key points
Key Highlights
- On March 16, 2025, Roivant Sciences, Inc., a wholly-owned subsidiary of Roivant Sciences Ltd., entered into a consulting agreement with former Chief Accounting Officer Rakhi Kumar.
- Ms. Kumar stepped down as Chief Accounting Officer effective February 20, 2025, as previously disclosed in a Form 8-K filed February 21, 2025.
- The consulting agreement has an 18-month term covering advisory and transition services as reasonably requested by RSI.
- During the term, Ms. Kumar remains eligible to continue vesting in her outstanding Company equity incentive awards.
- Outstanding unvested equity awards will fully vest at the end of the term, provided she complies with her obligations and the agreement is not earlier terminated.
- The filing includes no financial statements or quantitative financial results; its only exhibit is the cover page Interactive Data File.
03—Questions
Frequently Asked Questions
Who is Rakhi Kumar and what was her role?
Rakhi Kumar was Roivant's Chief Accounting Officer. The filing states she stepped down from that role effective February 20, 2025.
What arrangement did Roivant enter into with Ms. Kumar?
On March 16, 2025, Roivant Sciences, Inc. (RSI), a wholly-owned subsidiary of Roivant Sciences Ltd., entered into a consulting agreement with her. Under it, she will provide advisory and transition services as reasonably requested by RSI over an 18-month term.
How is Ms. Kumar compensated under the consulting agreement?
The filing states that she will be eligible to continue vesting in her outstanding Company equity incentive awards during the 18-month term. It does not describe any cash fees.
What happens to her equity awards at the end of the consulting term?
If she has complied with her obligations under the consulting agreement and related separation documentation, and the agreement has not been earlier terminated, any outstanding unvested Company equity incentive awards will fully vest at the end of the term.
Does this filing include any financial results?
No. The filing addresses only the executive transition and consulting arrangement under Item 5.02, and its only exhibit is the cover page Interactive Data File embedded in the Inline XBRL document.
04—Continue